J7172 Injection marstacim-hncq, 0.5 milligrams
J-Codes
Also known as: marstacim, Factor VIII recombinant
Injection of marstacim-hncq, a recombinant Factor VIII, supplied as 0.5 milligrams per dose for hemophilia A management.
Clinical Context
Used for treatment and prophylaxis of hemophilia A to prevent or control bleeding episodes in patients with Factor VIII deficiency.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.